skip to main content
Idioma:
Refinado por: Nome da Publicação: Lung Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Griesinger, Frank ; Eberhardt, Wilfried ; Nusch, Arnd ; Reiser, Marcel ; Zahn, Mark-Oliver ; Maintz, Christoph ; Bernhardt, Christiane ; Losem, Christoph ; Stenzinger, Albrecht ; Heukamp, Lukas C. ; Büttner, Reinhard ; Marschner, Norbert ; Jänicke, Martina ; Fleitz, Annette ; Spring, Lisa ; Sahlmann, Jörg ; Karatas, Aysun ; Hipper, Annette ; Weichert, Wilko ; Heilmann, Monika ; Sadjadian, Parvis ; Gleiber, Wolfgang ; Grah, Christian ; Waller, Cornelius F. ; Reck, Martin ; Rittmeyer, Achim ; Christopoulos, Petros ; Sebastian, Martin ; Thomas, Michael

Lung cancer (Amsterdam, Netherlands), 2021-02, Vol.152, p.174-184 [Periódico revisado por pares]

Ireland: Elsevier B.V

Texto completo disponível

Citações Citado por
2
KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype?
KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype?
Material Type:
Artigo 		Adicionar ao Meu Espaço

KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype?

Dempke, Wolfram C.M. ; Reck, Martin

Lung cancer (Amsterdam, Netherlands), 2021-09, Vol.159, p.10-17 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
3
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts
Material Type:
Artigo 		Adicionar ao Meu Espaço

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts

Früh, M. ; Panje, C.M. ; Reck, M. ; Blackhall, F. ; Califano, R. ; Cappuzzo, F. ; Besse, B. ; Novello, S. ; Garrido, P. ; Felip, E. ; O'Brien, M. ; Paz Ares, L. ; de Marinis, F. ; Westeel, V. ; De Ruysscher, D. ; Putora, P.M.

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.6-11 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
4
Targeted therapies for non-small cell lung cancer
Targeted therapies for non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeted therapies for non-small cell lung cancer

Dempke, Wolfram C.M ; Suto, Tamas ; Reck, Martin

Lung cancer (Amsterdam, Netherlands), 2010-03, Vol.67 (3), p.257-274 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
5
Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

Reinmuth, N ; Meyer, A ; Hartwigsen, D ; Schaeper, C ; Huebner, G ; Skock-Lober, R ; Bier, A ; Gerecke, U ; Held, C.-P ; Reck, M

Lung cancer (Amsterdam, Netherlands), 2014-03, Vol.83 (3), p.363-368 [Periódico revisado por pares]

Oxford: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
6
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Levy, Antonin ; Hendriks, Lizza E.L. ; Le Péchoux, Cécile ; Falk, Sally ; Besse, Benjamin ; Novello, Silvia ; Dingemans, Anne-Marie C. ; Hasan, Baktiar ; Reck, Martin ; Berghmans, Thierry ; Faivre-Finn, Corinne

Lung cancer (Amsterdam, Netherlands), 2019-10, Vol.136, p.145-147 [Periódico revisado por pares]

Ireland: Elsevier B.V

Texto completo disponível

Citações Citado por
7
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey
Material Type:
Artigo 		Adicionar ao Meu Espaço

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey

Pilotto, Sara ; Avancini, Alice ; Menis, Jessica ; Sperduti, Isabella ; Giaj Levra, Matteo ; Berghmans, Thierry ; Bironzo, Paolo ; Brandão, Mariana ; De Ruysscher, Dirk ; Edwards, John ; Faivre-Finn, Corinne ; Girard, Nicolas ; Greillier, Laurent ; Hendriks, Lizza ; Lantuejoul, Sylvie ; Mauer, Murielle ; Novello, Silvia ; O'Brien, Mary ; Reck, Martin ; Reguart, Noemi ; Remon, Jordi ; von der Thüsen, Jan ; Dingemans, Anne-Marie C. ; Besse, Benjamin ; Milella, Michele

Lung cancer (Amsterdam, Netherlands), 2022-07, Vol.169, p.94-101 [Periódico revisado por pares]

Ireland: Elsevier B.V

Texto completo disponível

Citações Citado por
8
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Liu, Stephen V ; Mok, Tony S K ; Nabet, Barzin Y ; Mansfield, Aaron S ; De Boer, Richard ; Losonczy, György ; Sugawara, Shunichi ; Dziadziuszko, Rafal ; Krzakowski, Maciej ; Smolin, Alexey ; Hochmair, Maximilian J ; Garassino, Marina C ; Gay, Carl M ; Heymach, John V ; Byers, Lauren A ; Lam, Sivuonthanh ; Cardona, Andrés ; Morris, Stefanie ; Adler, Leah ; Shames, David S ; Reck, Martin

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107418-107418, Article 107418 [Periódico revisado por pares]

Ireland

Texto completo disponível

Citações Citado por
9
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer

Schuette, Wolfgang ; Schneider, Claus-Peter ; Engel-Riedel, Walburga ; Schumann, Christian ; Kohlhaeufl, Martin ; Serke, Monika Heidi Ursel ; Hoeffken, Gert ; Kortsik, Cornelius ; Reck, Martin

Lung cancer (Auckland), 2017-01, Vol.8, p.217-229 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
10
Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174–184]
Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174–184]
Material Type:
Artigo 		Adicionar ao Meu Espaço

Corrigendum to “Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)” [Lung Cancer 152 (2021) 174–184]

Griesinger, Frank ; Eberhardt, Wilfried ; Nusch, Arnd ; Reiser, Marcel ; Zahn, Mark-Oliver ; Maintz, Christoph ; Bernhardt, Christiane ; Losem, Christoph ; Stenzinger, Albrecht ; Heukamp, Lukas C. ; Büttner, Reinhard ; Marschner, Norbert ; Jänicke, Martina ; Fleitz, Annette ; Spring, Lisa ; Sahlmann, Jörg ; Karatas, Aysun ; Hipper, Annette ; Weichert, Wilko ; Heilmann, Monika ; Sadjadian, Parvis ; Gleiber, Wolfgang ; Grah, Christian ; Waller, Cornelius F. ; Reck, Martin ; Rittmeyer, Achim ; Christopoulos, Petros ; Sebastian, Martin ; Thomas, Michael

Lung cancer (Amsterdam, Netherlands), 2021-07, Vol.157, p.167-167 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.